Prognostic Validation of the NINDS Common Data Elements for the Radiologic Reporting of Acute Traumatic Brain Injuries: A CENTER-TBI Study. by Vande Vyvere, T et al.
Original Articles
Prognostic Validation of the NINDS Common
Data Elements for the Radiologic Reporting
of Acute Traumatic Brain Injuries:
A CENTER-TBI Study
Thijs Vande Vyvere,1,2 Ezequiel De La Rosa,2 Guido Wilms,2,3 Daan Nieboer,5
Ewout Steyerberg,5,6 Andrew I.R. Maas,4 Jan Verheyden,2
Luc van den Hauwe,1 and Paul M. Parizel1; CENTER-TBI Participants and Investigators*
Abstract
The aim of this study is to investigate the prognostic value of using the National Institute of Neurological Disorders and Stroke
(NINDS) standardized imaging-based pathoanatomic descriptors for the evaluation and reporting of acute traumatic brain injury
(TBI) lesions. For a total of 3392 patients (2244 males and 1148 females, median age = 51 years) enrolled in the Collaborative
European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) study, we extracted 96 Common
Data Elements (CDEs) from the structured reports, spanning all three levels of pathoanatomic information (i.e., 20 ‘‘basic,’’ 60
‘‘descriptive,’’ and 16 ‘‘advanced’’ CDE variables per patient). Six-month clinical outcome scores were dichotomized into
favorable (Glasgow Outcome Scale Extended [GOS-E] = 5-8) versus unfavorable (GOS-E = 1-4). Regularized logistic regres-
sion models were constructed and compared using the optimism-corrected area under the curve (AUC). An abnormality was
reported for the majority of patients (64.51%). In 79.11% of those patients, there was at least one coexisting pathoanatomic
lesion or associated finding. An increase in lesion severity, laterality, and volume was associated with more unfavorable
outcomes. Compared with the full set of pathoanatomic descriptors (i.e., all three categories of information), reporting ‘‘basic’’
CDE information provides at least equal discrimination between patients with favorable versus unfavorable outcome (AUC =
0.8121 vs. 0.8155, respectively). Addition of a selected subset of ‘‘descriptive’’ detail to the basic CDEs could improve outcome
prediction (AUC = 0.8248). Addition of ‘‘advanced’’ or ‘‘emerging/exploratory’’ information had minimal prognostic value.
Our results show that the NINDS standardized-imaging based pathoanatomic descriptors can be used in large-scale studies and
provide important insights into acute TBI lesion patterns. When used in clinical predictive models, they can provide excellent
discrimination between patients with favorable and unfavorable 6-month outcomes. If further validated, our findings could
support the development of structured and itemized templates in routine clinical radiology.
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Introduction
Traumatic Brain Injury (TBI) encompasses a vast spectrumof acute pathoanatomic lesions.1,2 Evaluation of these lesions
on non-contrast computed tomography (NCCT) scans is often
complex and challenging, and has been associated with significant
observer error and variability.3,4 Moreover, substantial differences
exist in how lesions are reported and classified, even between ex-
pert neuroradiologists.3 Terminology also may differ between
various medical disciplines, which makes it difficult to compare
data from clinical trials or studies.2
In order to minimize these observer differences, to facilitate
clinical effectiveness research, data sharing, data aggregation for
registries, data interoperability, and the development and testing of
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computerized models, multiple instances have advocated a more
standardized way to evaluate and report TBI lesions.2,5 One way to
achieve this is by using consistent language in the form of Common
Data Elements (CDEs). CDEs are logical units of data that are
clearly conceptualized by definitions and can be used across dif-
ferent studies.
In 2010, a consortium of TBI experts from the National Institutes of
Health and National Institute for Neurological Disorders and Stroke
(NINDS) created a set of radiologic CDEs, which includes controlled
terms and standardized definitions to characterize the different
types of pathoanatomic lesions encountered on imaging of TBI
patients.2,6 Information pertaining to these lesions can be classified
into three levels of successive detail: 1) ‘‘basic’’ or ‘‘supplemental–
highly recommended’’ information (presence vs. absence); 2) ‘‘de-
scriptive’’ or ‘‘supplemental’’ information (location, size, extent, etc.);
and 3) ‘‘advanced’’ or ‘‘emerging/exploratory’’ information (subtype,
quantitative volumetry, etc.).2,6
Several large-scale multi-center TBI studies have implemented this
kind of standardized and structured CDE characterization.7,8 Research
shows that good interobserver and intraobserver agreement can be
achieved for the reporting of ‘‘basic’’ data elements.9,10 However, the
value and prognostic importance of reporting these different pathoa-
natomic descriptors has not been extensively investigated. For ex-
ample, the majority of ‘‘descriptive’’ and ‘‘advanced’’ data elements
have not been fully validated or correlated with clinical outcome.6 A
thorough prognostic validation is therefore urgently needed.
The main purpose of this study is to investigate the value of using
the recommended NINDS standardized pathoanatomic terms and
definitions for reporting acute TBI lesions. More specifically, we
aim to explore acute NCCT lesion patterns and to investigate the
prognostic value of the different pathoanatomic descriptors by
building regularized logistic regression models that cover all suc-
cessive levels of lesion information.
Methods
Study design, setting, and ethics statement
The Collaborative European NeuroTrauma Effectiveness Re-
search in Traumatic Brain Injury (CENTER-TBI) project included
a multi-center longitudinal and observational study (registered at
ClinicalTrials.gov: NCT02210221).8 Patients with a clinical diag-
nosis of TBI and an indication for CT scanning were enrolled in
three strata, differentiated by care path (i.e., emergency room [ER],
admission, or intensive care unit [ICU] stratum). The study pro-
tocol was approved by the national and local ethics committees for
each participating center. Informed consent, including use of data
for other research purposes, was obtained in each subject according
to local regulations. Patient data was de-identified and coded by
means of a Global Unique Patient Identifier.
NCCT evaluation
A total of 4037 initial NCCT scans, from 55 different European
centers, were forwarded to a centralized imaging repository and
evaluated by a central review panel between January 2015 and
December 2018. The review panel consisted of three protocol-
trained reviewers (i.e., one expert neuroradiologist with over 25
years of experience and two trained neuroscientists with expertise
in radiologic neuroanatomy). All readers were blinded to clinical
patient information, except for gender, age, and care path stratum.
Pathoanatomic data elements were evaluated and entered directly
into digital custom-made multi-tiered structured templates (Fig. 1
for an example). Each synoptic report was generated as a draft by
one of the two neuroscientists, followed by a double-reading and
validation by the expert neuroradiologist.
NINDS TBI CDEs
A total of 96 CDEs (20 ‘‘basic,’’ 60 ‘‘descriptive,’’ and 16
‘‘advanced’’) were extracted from the synoptic reports for this
study. Three variables, that were not clearly defined in the NINDS
CDEs, were evaluated extra and incorporated in the study as
‘‘descriptive’’ or ‘‘supplemental’’ pathoanatomic descriptors (i.e.,
total lesion volume, herniation, and pre-existing lesions). Three-
dimensional skull reconstructions were made to evaluate fractures
for each patient. Midline shift was measured using the A/2–B
method,11 and reported when higher than 5 mm. Volume estima-
tions for hematomas and contusions were performed using the
A · B · C/2 method, where A is the width, B is the depth, and C is
the length of the lesion.12 Pericontusional edema was included in
the lesion measurements. For this study, where possible, location
variables were simplified by collapsing them into unilateral or bi-
lateral (Supplementary Tables S1-S3).
Outcome and final dataset
For 3392 of the 4037 reviewed patients (84%), the 6-month
outcome (GOS-E) score was retrieved from the CENTER-TBI core
dataset via the Neurobot platform (International Neuroinformatics
Coordinating Facility [INCF], version 1.2). Outcome scores were
dichotomized (i.e., favorable outcome: GOS-E = 5-8, unfavorable
outcome: GOS-E = 1–4), in accordance with previous studies.13,14
Venous sinus injury was rarely reported. Unfortunately, when re-
ported, no outcome data was available. This resulted in 19 ‘‘basic’’
CDEs and a total of 95 predictor variables for regression analysis.
Statistical analysis
Descriptive statistics. Descriptive statistics were used to ana-
lyze patient demographics and lesion frequencies. Age between pa-
tients with favorable versus unfavorable outcome was compared using
the Student’s t-test. Gender distribution was examined using the chi-
squared test. Non-parametric Mann-Whitney U tests were per-
formed to investigate differences in the median volume of lesions.
Regularized logistic regression. To reduce the complexity
of our large set of variables and to have an optimal performing
model with low variance, regularized logistic regression was used.
Before building the models, continuous and categorical variables
were scaled by dividing by two times the standard deviation.15 Two
base ridge regression models were built: 1) one with the full set of
CDEs (CDEfull) and 2) one with only ‘‘basic’’ or ‘‘supplemental–
highly recommended’’ CDEs (CDEbasic). Ridge regression is a
form of regularized regression where a penalty is imposed to the
model for having too many variables. Regression coefficients of the
variables that are less contributive are typically shrunk toward, but
not equal to, zero. They are penalized but stay in the model. Least
Absolute Shrinkage and Selection Operator (LASSO) regression is
another regularized regression technique that shrinks coefficients of
less contributing variables exactly to zero.16 In contrast to ridge
regression, this technique reduces a large set of variables to only the
important ones by performing variable or feature selection. The
penalty that is given to the variables in regularized regression
models is controlled by two hyperparameters: 1) lambda (k), which
accounts for the amount of regularization used in the model and 2)
alpha (a), which accounts for the relative importance of the L1
(LASSO) and L2 (ridge) regularizations (i.e., ridge regression
a = 0; LASSO regression a = 1). Addressing the expected multi-
collinearity in our data, we constructed four models with elastic net
penalties, which uses both ridge and LASSO (i.e., 0 < a < 1) reg-
ularization.17 This shrinks some regression coefficients and others















































are set exactly to zero. Elastic net regression typically performs
better than LASSO regression in the presence of highly correlated
predictors17 (see Table 1 for model characteristics). For all models,
hyperparameters were chosen using 10 · 10 cross-validation. The
stability of the variable selection procedure and the optimism-
corrected performance of the models was assessed in a 100-
repetition bootstrap resampling procedure.18
Results
Descriptive statistics
Our dataset consisted of 2244 males (66.20%) and 1148 females
(33.80%), with a median age of 51 (0–96 years). A total of 818
patients had unfavorable outcome (24%), for which no gender
FIG. 1. Example of a structured and itemized template (i.e., for skull fracture), used for standardized evaluation and reporting in the
Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) study. The ‘‘basic’’ or
‘‘supplemental–highly recommended’’ tier refers to the presence or absence of an abnormality. The ‘‘descriptive’’ or ‘‘supplemental’’ tier
gives more details about the location or volume. The ‘‘advanced’’ or ‘‘emerging/exploratory’’ tier gives extra information about the nature
of the lesion or involves an emerging technique.
Table 1. Model Characteristics
# Model Input CDEs N(%) Regression Selection characteristics
1 CDEfull 95 (100%) Ridge Base model: Shrinkage of regression coefficients, no variable selection
2 CDEbasic 19 (20%) Ridge Base model: Shrinkage of regression coefficients, no variable selection
3 CDEbasic’ 19 (20%) Elastic Net Subset selection on basic variables
4 CDEbasic+descriptive 79 (83%) Elastic Net Subset selection on descriptive variables, basic CDEs not penalized
5 CDEbasic+advanced 35 (37%) Elastic Net Subset selection on advanced variables, basic CDEs not penalized
6 CDEbasic+descriptive+advanced 95 (100%) Elastic net Subset selection on descriptive and advanced variables, basic CDEs
not penalized
CDE, Common Data Element.















































differences were found (v2 = 0.025, p = 0.8755). However, patients
with unfavorable outcome were older (mean = 58.1 vs. 46.4;
p < 0.0001). Of all patients, 691 were in the ER (20,4%), 1133 were
admitted to the ward (33,4%) and 1568 were in the ICU (46%).
Pathoanatomic lesion frequency and co-occurrence
An abnormality was reported for the majority of patients (64.51%).
If a skull fracture was present, patients had an intracranial abnor-
mality in 92% of cases. The most common acute finding was trau-
matic subarachnoid hemorrhage (tSAH; 46.55%), followed by skull
fracture (38.33%), contusion (33.31%), and acute subdural hematoma
(SDH; 29.83%; Fig. 2). When an abnormality was found on the initial
NCCT scan, in 79.11% of the cases there was at least one co-existing
pathoanatomic lesion or associated finding. In many patients, the
most common co-existing pathoanatomic lesion types were skull
fractures with tSAH (28.50% of patients), contusions with tSAH
(27.30% of patients), skull fractures and contusion (24.20% of pa-
tients), and acute SDH with tSAH (23.20% of patients; Fig. 3).
Pathoanatomic lesion laterality
Compared with unilateral lesions, bilateral lesions were asso-
ciated more with unfavorable outcome (e.g., bilateral vs. unilateral
acute subdural hematoma, 67.60% vs. 38%; bilateral vs. unilateral
frontal contusion, 51.20% vs. 33.90%; bilateral vs. unilateral pa-
rietal contusion, 80.0% vs. 52.60%; bilateral vs. unilateral con-
tusion of the basal ganglia, 80.0% vs. 66.70%; and bilateral vs.
unilateral axonal injury in the genu of the corpus callosum, 100.0%
vs. 46.20%).
Pathoanatomic lesion severity
An increase in the amount of tSAH was associated with more
unfavorable outcome (basal cistern trace: 51.50% vs. moderate:
61.90% vs. full: 83.70%; bilateral cortical trace: 43.30% vs. mod-
erate 66.20% vs. full 81.60%). A higher degree of compression of
the cisterns also was more associated with unfavorable outcome
(compressed vs. obliterated suprasellar cistern: 60.60% vs. 85.40%,
quadrigeminal cistern: 63.60% vs. 82.60%, ambient cistern: 57.20%
vs. 83.10%, cerebellomedullary cistern: 71.80% vs. 87%).
Pathoanatomic lesion volumes
For specific lesion types, the median volumes were signifi-
cantly higher in patients with unfavorable outcome than in pa-
tients with favorable outcome (i.e., total lesion volume: 43.14
vs. 8.59 mL, p < 0.0001; acute subdural hematoma volume: 31.48
vs. 10.92 mL, p < 0.0001; and contusion volume: median = 11.420 vs.
3.005 mL, p < 0.0001). The differences between other extra-axial
bleedings were not significant (i.e., median epidural hematoma
volume: 5.98 vs. = 4.38 mL, p = 0.2417; mixed subdural hematoma:
41.84 vs. 27.51 mL, p = 0.43 extra-axial hematoma: 3.62 vs.
FIG. 2. Frequencies of different ‘‘basic’’ pathoanatomic lesion types encountered on the initial non-contrast computed tomography of
a subset of 3392 patients, enrolled in the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury
(CENTER-TBI) study.















































0.90 mL, p = 0.11; and chronic/subacute subdural hematoma: 12.10
vs. 19.64 mL, p = 0.46).
Regularized logistic regression
Base models. Table 2 shows the optimism-corrected area un-
der the receiver operating characteristic curve and corresponding
confidence intervals for the different logistic regression models. Ap-
plying ridge regression to the full set of CDEs (CDEfull) yielded good
discrimination between patients with favorable versus unfavorable
outcome (area under the curve [AUC] = 0.8121). Applying ridge re-
gression to the ‘‘basic’’ CDEs only (CDEbasic), yielded a slightly
higher discrimination (AUC = 0.8155). Mean regression coefficients
of the bootstrapped samples for the ‘‘basic’’ CDEs are shown in
FIG. 3. Co-occurrence matrix of different ‘‘basic’’ pathoanatomic lesion types encountered on the initial non-contrast computed
tomography of a subset of 3392 patients, enrolled in the Collaborative European NeuroTrauma Effectiveness Research in Traumatic
Brain Injury (CENTER-TBI) study.








1 CDEfull Ridge 95 (100%) 95 (100%) 0.8121 (0.8031–0.8179)
2 CDEbasic Ridge 19 (20%) 19 (20%) 0.8155 (0.8086–0.8203)
3 CDEbasic’ Elastic Net 19 (20%) 15 (16%) 0.8169 (0.8057–0.8182)
4 CDEbasic+descriptive Elastic Net 79 (83%) 48 (51%) 0.8248 (0.8177–0.8361)
5 CDEbasic+advanced Elastic Net 35 (37%) 28 (30%) 0.8179 (0.8107–0.8232)
6 CDEbasic+descriptive+advanced Elastic net 95 (100%) 61 (64%) 0.8010 (0.7827–0.8161)
*Median selected CDEs during bootstrapping. For CDEbasic+descriptive, CDEbasic+advanced and CDEbasic+descriptive+advanced, 19 basic CDEs were kept fixed
in the models.
CDE, Common Data Element; AUROC, area under the receiver operating characteristic curve; CI, confidence interval.















































Supplementary Table S4, indicating substantial prognostic importance
of vascular injury, ischemia, brain swelling, subdural hematoma, in-
traventricular hemorrhage, cisternal compression and tSAH.
Variable selection and selection stability of elastic net
models. Table 2 shows the total frequency of retained pathoana-
tomic variables in the different elastic net models. During boot-
strapping of the CDEbasic’ model, a median of 15 out of 19 variables
were selected in at least 50% of the bootstrap samples (Fig. 4).
Traumatic aneurysm, ischemia, skull fracture, and ventricular com-
pression were not commonly selected (i.e., <50%). Compared with
the base models, the CDEbasic’ model slightly increased discrimi-
nation (Table 2).
The ‘‘basic’’ pathoanatomic data elements were further kept fixed
in the elastic net models by not penalizing them and variable selection
was performed only on the ‘‘descriptive’’ and ‘‘advanced’’ informa-
tion. During bootstrapping of the CDEbasic+descriptive model, a median
of 29 out of 61 ‘‘descriptive’’ variables were selected in at least 50% of
the bootstrap samples (Table 2). For the CDEbasic+descriptive+advanced
model, a median of 34 out of 61 ‘‘descriptive’’ variables were selected
in at least 50% of the bootstrap samples (Table 2), of which 28 vari-
ables were co-selected in both models (Fig. 5A).
During bootstrapping of the CDEadvanced model, a median of
nine of 16 variables were selected in at least 50% of the bootstrap
samples. For the CDEbasic+descriptive+advanced model, a median of
eight of 16 ‘‘advanced’’ variables were selected, of which all 8 were
co-selected in both models (Fig. 5B). The CDEadvanced model slightly
increased the AUC, but adding ‘‘advanced’’ descriptors to the ‘‘basic’’
and ‘‘descriptive’’ information performed worse than the base models
(Table 2). The best classification performance was achieved by the
CDEbasic+descriptive model (Table 2). Table 3 shows the CDEs, with
successive levels of detail, that were selected by the original models.
Discussion
Our study is the first large-scale effort to investigate the value of
using NINDS standardized pathoanatomic terms and definitions for
the evaluation and reporting of acute TBI lesions. Our findings
show that this kind of structured CDE characterization, with mul-
tiple levels of lesion detail, can be used in large-scale studies and
can provide important insights into common and uncommon lesion
patterns. For instance, we confirm the expectation that most TBI
patients with a lesion on the initial NCCT scan, have co-existing
pathology,6 and that certain pathoanatomic entities tend to co-occur.
Our study also indicates that standardized imaging-based pathoa-
natomic descriptors can be used to build strong clinical predictive
models. In particular, we illustrated that regularized logistic regression
models, using acute NCCT-based pathoanatomic data elements as
predictors, can provide excellent discrimination between patients with
favorable and unfavorable outcomes after TBI. Interestingly, how-
ever, the greatest amount of prognostic information was provided by
‘‘supplemental–highly recommended’’ or ‘‘basic’’ data elements (i.e.,
presence or absence of lesions), which corroborates this set of pa-
thoanatomic terms as essential imaging elements for clinical studies.
FIG. 4. Percentage of ‘‘basic’’ Common Data Elements (CDEs) selected during the optimism-corrected bootstrapping procedure for
the CDEbasic’ model. Note: only variables are shown that were selected in at least 50% of the bootstrap samples.















































FIG. 5. (A) Percentage of ‘‘descriptive’’ variables selected during the optimism-corrected bootstrapping procedure for the Common
Data Elements (CDE)basic+descriptive and CDEbasic+descriptive+advanced models. (B) Percentage of ‘‘advanced’’ variables selected during the
optimism-corrected bootstrapping procedure for the CDEbasic+advanced and the CDEbasic+descriptive+advanced models. Note: Only variables
















































Nevertheless, the best prognostic model in our study contained a
subset of selected ‘‘descriptive’’ or ‘‘supplemental’’ data elements
added to the ‘‘basic’’ information. More specifically, distinct lo-
cations, laterality, and volumes of certain pathoanatomic entities
improved discrimination performance. For example, tSAH loca-
tion, laterality and degree was consistently selected, together with
the volume of acute subdural hematomas, contusions, and the pres-
ence of pre-existing lesions. Traumatic axonal injuries (i.e., capsula
interna, genu of the corpus callosum and brainstem) location and,
among others, the sum of all estimated lesion sizes (i.e., total lesion
volume) also provided important prognostic information. These
findings are very much in line with previous studies.19–24
Interestingly, however, the majority of ‘‘descriptive’’ and ‘‘ad-
vanced’’ data elements were extraneous to predict good or bad
outcome in our study. One possible explanation for this finding is
that certain details are redundant for dichotomized GOS-E out-
comes. For example, in many cases when cisternal compression is
reported, multiple cisterns are compressed simultaneously, which
may render this extra information redundant. However, these de-
tails might be relevant for other outcomes of interest.
The call for using standardized language in clinical radiology
routine is also growing.25 Unfortunately, radiologists still report
TBI lesions using unstructured narrative free-text and are known to
underreport volumes in clinical routine.26 In addition, more than a
Table 3. Selected CDE Variables by the Original Elastic Net Regression Models
Basic CDEs Descriptive information Advanced information





1 Skull fracture - Pneumocephalus - Comminuted, depressed Comminuted
2 Extra-axial hematoma + - - - -
3 Epidural hematoma + Parietal, Occipital - - -
4 Subdural hematoma,
acute
+ Volume Volume Number -
5 Subdural hematoma,
subacute/chronic.



















8 Vascular dissection + - - - -
9 Traumatic aneurysm - - - - -
10 Venous sinus injury - - - - -
11 MLS + - - - -








- - - -










+ 3rd ventricle - - -












+ - - - -
19 Ischemia + - - - -









CDE, Common Data Element; MLS, midline shift.















































third of neurosurgeons solely rely on visual intuition for their
surgical decision-making, despite volume-based surgical and pa-
tient management recommendations and guidelines.27,24
Radiologists often argue that that structured reporting systems,
using a standardized lexicon, might diminish efficiency, reduce
the speed of reporting and cause too much distraction in a field
with broad pathology. However, our study indicates that ‘‘basic’’
or ‘‘supplemental–highly recommended’’ pathoanatomic terms,
as recommended by the NINDS working group, offer an essential
framework of strong outcome predictors that can be incorporated
in itemized structured reporting templates. Important details (i.e.,
volume and location) can be added, based on the clinical
or prognostic question of the treatment team. Moreover, auto-
matic quantification of lesion volume is already within reach.28
Not only has this shown to improve prognostic models,29 it could
offer a more complete, objective and consistent evaluation of TBI
lesions in radiology routine. More ‘‘advanced’’ or ‘‘emerging/
exploratory’ techniques are currently under validation. When
incorporated into CDE-based reporting, they could help improve
the standardization of clinical decision-making and treatment of
acute TBI patients.
We acknowledge several limitations to our study. For example,
proportional odds regression might offer some efficiency gains
compared with conventional binary logistic regression with GOS-
E.30 However, regularized logistic regression with elastic net
penalties is a statistically robust method for variable selection and
was optimally suited for our study. Another limitation is that some
variables (i.e., vascular injuries and venous sinus injury) were
seldomly reported. These injuries are rare and their diagnosis is
difficult to make based on NCCT imaging alone, without CT an-
giography or venography to confirm. In our study, CT angiograms
were rarely uploaded. Unfortunately, of those reported, outcome
data was not always present. In the future, an increased sample size
of these data elements and the incorporation of other imaging
modalities (magnetic resonance imaging [MRI], CT- angiography
or venography, etc.) could reveal other important descriptors. Fi-
nally, our work focusses only on the initial NCCT. Certain sec-
ondary injuries (e.g., ischemia, swelling, etc.) are often only
detected on a follow-up NCCT scan. We did not include or in-
vestigate CDEs that are related to follow-up (e.g., brain atrophy,
lesion volume change) or more ‘‘advanced’’ and ‘‘emerging/
exploratory’’ neuroimaging techniques (diffusion tensor imaging,
etc.). Future studies might address these questions, in addition to
investigating the value of using standardized imaging-based pa-
thoanatomic data elements in predicting neuro-worsening, or
changes in patient status, that might need specific interventions to
improve clinical outcome.
Conclusion
Our study represents the first large-scale effort to scientifically
vet the NINDS pathoanatomic terms and definitions for the re-
porting of acute TBI lesions. We show that these standardized-
imaging based pathoanatomic descriptors can be used in large-scale
studies and provide important insights into common and uncom-
mon acute lesion patterns. When incorporated in clinical prediction
models, specific standardized NCCT-based data elements can offer
excellent discrimination between patients with favorable and un-
favorable 6-month outcomes after TBI. Further validation of our
findings can also support the development of consensus-based
itemized templates for structured reporting of TBI lesions in clin-
ical radiology routine.
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naud, Anesthesie-Réanimation, Assistance Publique—Hopitaux de
Paris, Paris, France; Dashiell Gantner, ANZIC Research Center,
Monash University, Department of Epidemiology and Preventive
Medicine, Melbourne, Australia; Guoyi Gao, Department of Neu-
rosurgery, Shanghai Renji Hospital, Shanghai Jiaotong Uni-
versity/School of Medicine, Shanghai, China; Pradeep George,
Karolinska Institutet, INCF International Neuroinformatics Co-
ordinating Facility, Stockholm, Sweden; Alexandre Ghuysen,
Emergency Department, CHU, Liège, Belgium; Lelde Giga, Neu-
rosurgery Clinic, Pauls Stradins Clinical University Hospital, Riga,
Latvia; Ben Glocker, Department of Computing, Imperial College
London, London, United Kingdom; Jagoš Golubovic, Department
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Fiona Lecky, Emergency Medicine Research in Sheffield, Health
Services Research Section, School of Health and Related Research
(ScHARR), University of Sheffield, Sheffield, United Kingdom; Rolf
Lefering, Institute of Research in Operative Medicine (IFOM), Wit-
ten/Herdecke University, Cologne, Germany; Valerie Legrand, VP
Global Project Management CNS, ICON, Paris, France; Aurelie Le-
jeune, Department of Anesthesiology-Intensive Care, Lille University
Hospital, Lille, France; Leon Levi, Department of Neurosurgery,
Rambam Medical Center, Haifa, Israel; Roger Lightfoot, Department
of Anesthesiology and Intensive Care, University Hospital South-
hampton NHS Trust, Southhampton, United Kingdom; Hester Lings-
ma, Department of Public Health, Erasmus Medical Center-University
Medical Center, Rotterdam, the Netherlands; Ana M. Castaño
León, Department of Neurosurgery, Hospital Universitario 12 de
Octubre, Madrid, Spain; Marc Maegele, Cologne-Merheim Medi-
cal Center (CMMC), Department of Traumatology, Orthopedic
Surgery and Sportmedicine, Witten/Herdecke University, Cologne,
Germany; Marek Majdan, Department of Public Health, Faculty of
Health Sciences and Social Work, Trnava University, Trnava,
Slovakia; Alex Manara, Intensive Care Unit, Southmead Hospital,
Bristol, Bristol, United Kingdom; Geoffrey Manley, Department of
Neurological Surgery, University of California, San Francisco,
California; Costanza Martino, Department of Anesthesia and In-
tensive Care, M. Bufalini Hospital, Cesena, Italy; Hugues Maré-
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